Share
* In the USA, CytoSorb is an investigational device and not authorized / cleared / approved by the US FDA for commercialization.
Search for ""
Search for ""
Locations

We are here for you – wherever you are

CytoSorbents’ global reach with corporate offices in New Jersey/USA and Berlin/Germany and distributors and partners around the world ensures immediate support wherever you are. These diverse locations cater to your needs and make your interactions with us seamless and convenient.

CytoSorbents Corporation & CytoSorbents Medical Inc.

 

305 College Road East
Princeton, New Jersey 08540
United States of America
Phone: +1 732-329-8885
Fax: +1 732-329-8650

[email protected]

CytoSorbents Europe GmbH

 

Müggelseedamm 131
12587 Berlin
Germany
Phone: +49 30 654 99 145
Fax +49 30 654 99 146

[email protected]

CytoSorbents worldwide

 

Contact your distributor directly in your country

Find your contact
Clinical Inquiries

Dr. Efthymios Deliargyris
Chief Medical Officer

[email protected]

Investor Inquiries

Peter Mariani, CFO
CytoSorbents Investor Relations & Corporate Communications
Phone: +1 732-329-8885

[email protected]

Media Inquiries

Aman Patel, CFA
ICR-Westwicke

[email protected]

CytoSorbents

Voices around the world

world map
Critical Care
Dr. Candido Amador
Panama City, Panama

In my experience the vasopressor doses decreased, biomarkers of sepsis (…) and the inflammatory response as well as multiple organ function improved.

Critical Care
Dr. Euclides Cruz
Pereira, Colombia

I remember a 23-year old man, who ingested a toxic substance: paraquat. No antidote, mortality is approx. 90%. CytoSorb worked really well, he survived.

Cardiovascular
Prof. Dr. Yeong-Hoon Choi
Bad Nauheim, Germany

We were able to decrease the need for circulatory supporting medications accordingly, very, very quickly to a tolerable level.

View All Voices